For example, prolyl hydroxylase domain enzymes (PHD), the classical Hypoxia Inducible Factor-1alpha (HIF-1α) hydroxylation-modifying enzymes under normoxia, have been identified as the critical targets of iron chelators that are clinically beneficial in many neurological disorders [50,51]. This evidence concerns the gene PDC and nervous system disorder.